Cargando…
Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide
A 42-year-old Japanese man developed Churg–Strauss syndrome 7 years after being diagnosed with chronic eosinophilic pneumonia. Prominent eosinophilia, subcutaneous nodules, and neuropathy in the left leg were seen. A pathological diagnosis of necrotizing vasculitis was determined by a biopsy of a su...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184514/ https://www.ncbi.nlm.nih.gov/pubmed/25473575 http://dx.doi.org/10.1002/rcr2.56 |
_version_ | 1782337854263787520 |
---|---|
author | Umeda, Akira Yamane, Tateki Takeuchi, Jin Imai, Yasuo Suzuki, Keisuke Yumura, Wako |
author_facet | Umeda, Akira Yamane, Tateki Takeuchi, Jin Imai, Yasuo Suzuki, Keisuke Yumura, Wako |
author_sort | Umeda, Akira |
collection | PubMed |
description | A 42-year-old Japanese man developed Churg–Strauss syndrome 7 years after being diagnosed with chronic eosinophilic pneumonia. Prominent eosinophilia, subcutaneous nodules, and neuropathy in the left leg were seen. A pathological diagnosis of necrotizing vasculitis was determined by a biopsy of a subcutaneous nodule. The leg pain was severe and there was prominent atrophy of the thigh and calf, but the muscle weakness was mild. Serum anti-myeloperoxidase anti-neutrophil cytoplasmic antibody was positive. Because the initial treatment with an intravenous methylprednisolone pulse at 1 g/day for 3 days was not sufficient, a onetime treatment with intravenous cyclophosphamide at 15 mg/kg and intravenous immunoglobulin therapy (IVIG) at 400 mg/kg/day for 5 days were administered. Peripheral eosinophilia improved and the leg pain significantly improved. IVIG was repeated 1 month later and symptoms gradually improved further. The early diagnosis of Churg–Strauss syndrome and the early initiation of IVIG with cyclophosphamide were thought to be important. |
format | Online Article Text |
id | pubmed-4184514 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BlackWell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-41845142014-12-03 Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide Umeda, Akira Yamane, Tateki Takeuchi, Jin Imai, Yasuo Suzuki, Keisuke Yumura, Wako Respirol Case Rep Case Reports A 42-year-old Japanese man developed Churg–Strauss syndrome 7 years after being diagnosed with chronic eosinophilic pneumonia. Prominent eosinophilia, subcutaneous nodules, and neuropathy in the left leg were seen. A pathological diagnosis of necrotizing vasculitis was determined by a biopsy of a subcutaneous nodule. The leg pain was severe and there was prominent atrophy of the thigh and calf, but the muscle weakness was mild. Serum anti-myeloperoxidase anti-neutrophil cytoplasmic antibody was positive. Because the initial treatment with an intravenous methylprednisolone pulse at 1 g/day for 3 days was not sufficient, a onetime treatment with intravenous cyclophosphamide at 15 mg/kg and intravenous immunoglobulin therapy (IVIG) at 400 mg/kg/day for 5 days were administered. Peripheral eosinophilia improved and the leg pain significantly improved. IVIG was repeated 1 month later and symptoms gradually improved further. The early diagnosis of Churg–Strauss syndrome and the early initiation of IVIG with cyclophosphamide were thought to be important. BlackWell Publishing Ltd 2014-06 2014-04-14 /pmc/articles/PMC4184514/ /pubmed/25473575 http://dx.doi.org/10.1002/rcr2.56 Text en © 2014 The Authors. Respirology Case Reports published by John Wiley & Sons Ltd on behalf of The Asian Pacific Society of Respirology. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Case Reports Umeda, Akira Yamane, Tateki Takeuchi, Jin Imai, Yasuo Suzuki, Keisuke Yumura, Wako Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide |
title | Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide |
title_full | Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide |
title_fullStr | Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide |
title_full_unstemmed | Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide |
title_short | Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide |
title_sort | marked improvement of churg–strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184514/ https://www.ncbi.nlm.nih.gov/pubmed/25473575 http://dx.doi.org/10.1002/rcr2.56 |
work_keys_str_mv | AT umedaakira markedimprovementofchurgstrausssyndromeneuropathybyintravenousimmunoglobulinandcyclophosphamide AT yamanetateki markedimprovementofchurgstrausssyndromeneuropathybyintravenousimmunoglobulinandcyclophosphamide AT takeuchijin markedimprovementofchurgstrausssyndromeneuropathybyintravenousimmunoglobulinandcyclophosphamide AT imaiyasuo markedimprovementofchurgstrausssyndromeneuropathybyintravenousimmunoglobulinandcyclophosphamide AT suzukikeisuke markedimprovementofchurgstrausssyndromeneuropathybyintravenousimmunoglobulinandcyclophosphamide AT yumurawako markedimprovementofchurgstrausssyndromeneuropathybyintravenousimmunoglobulinandcyclophosphamide |